Diabetes Mellitus, Type 2 Clinical Trial
Official title:
GLucose Monitoring Programme SingaporeE (GLiMPSE) - Phase 1
This phase 1 study is a non-randomized, single-arm, multi-center study that is designed to evaluate the feasibility and acceptability of the flash glucose monitoring system together with a structured education programme in individuals with Type 2 Diabetes.
Up to 30 adults and 15 children will be recruited from 3 different sites in Singapore.
For Adults, this phase consists of screening and intervention periods.
Screening Period (Week -2 to -1):
Participants will be asked to wear a blinded flash glucose monitoring system and will be
asked to continue testing their capillary glucose readings at least once daily for 2 weeks
(week -2 to week -1). Sensor glucose measurements are not available to both participants and
investigators during this screening period. Participants who are able to wear the sensor for
the 2 weeks, and are monitoring their capillary glucose levels at least 70% of the time for
the 2 weeks (>10 readings/2weeks), will proceed on with the intervention period.
Intervention Period (Week 0 - 26):
Participants will wear a personal version of the flash glucose monitoring system continuously
for the next 6 weeks. After these 6 weeks, they will wear the sensor intermittently (one
sensor lasting 2 weeks, per 4 weeks) for the following 18 weeks.Participants in this arm will
receive an education package that consists of Diabetes nurse educator and/or dietitian
appointments during weeks 0, 2, 6 and 24. After week 24, they will put on a blinded sensor
for the last 2 weeks of the intervention period (week 25 to week 26). HbA1c will be monitored
at weeks 0, 14 and 24. Questionnaires will be administered to assess acceptability of wear,
and perceived value to the end-user.
Paediatric participants will not undergo blinded sensor wear but will undergo the
intervention period, with the schedule of wear identical to the adults'. The education
curriculum will be age-appropriate and will be delivered over weeks 0, 2, 6, 12, and 24.
Their HbA1c will be monitored at week 0, 12 and 24. Questionnaires will be administered to
assess acceptability of wear, and perceived value to the end-user.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |